CDK4 and neoplasm: Taken together, our data suggest that the global activation of the PI3K/AKT/mTOR signaling axis in tumors with short-term/lack of response to CDK4/6 inhibition in combination with ET extends beyond the tumor compartment into the surrounding tumor microenvironment.